Navigation Links
UofL biostatistician to develop statistical model that could help answer medical questions
Date:3/2/2011

LOUISVILLE, Ky. - A University of Louisville professor is developing a statistical model that, among other things, may help determine what prolongs cancer free survival.

Somnath Datta, PhD, a professor in the Department of Bioinformatics and Biostatistics at the UofL School of Public Health and Information Sciences, and his team will incorporate medical and genomic data into the statistical model to find better answers to scientific questions.

A statistical model describes how one or more random variables relates to other variables. A multi-state model, which is the type Datta and his team are developing, looks at process for example, how a person, moves from one state to another over a period of time.

For someone with cancer, the model could analyze how the disease progresses from one stage to another. Or, for a patient in remission, the model might help determine what prolongs cancer free survival. Datta could incorporate all these factors into his statistical model.

The new statistical model will allow for broad inspection of patient patterns and data collection that are more practical.

"The model will be derived from empirical evidence - based on observation or experience - rather than unverifiable mathematical laws," Datta said. "As a result, the prediction from the methodology will be more robust and less likely to include model misspecification errors."

In addition to having applications to cancer research, the new statistical method will be applicable to many other disciplines ranging from engineering to political science that deal with staged systems or any system that can transition from one phase or stage to another. In politics, for instance, this would involve all the elements from planning a campaign to taking office.

Datta recently received a two year grant from the National Security Agency (NSA) under the Mathematical Sciences Program for this project. Work is expected to begin this month.


'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Related biology news :

1. Gene variants in autism linked to brain development
2. Researchers develop curious snapshot of powerful retinal pigment and its partners
3. Just like cars, developmental genes have more than 1 way to stop
4. Stanford researchers develop new technology for cheaper, more efficient solar cells
5. Further research needed to develop evidence-based nutrition guidelines for cancer survivors
6. Ben-Gurion U. part of EU consortium to develop robots that selectively pick fruit
7. Ben-Gurion U. researchers develop techniques to manipulate plant adaption in arid climates
8. Optiqua-NTU partnership to develop next-generation sensor technology
9. Partnership of genes affects the brains development
10. Team hopes to cut years off development time of new antibiotics
11. Offspring of female rats given folic acid supplements develop more breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... , España y TORONTO , 19 de diciembre ... Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un ... en varios tipos de tumor en 2017, con múltiples sitios previstos ... ... clase con objetivo en el factor inhibidor de leucemia (LIF), una ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... , January 23, 2017 ... Model Market by Type (Genetic, Cell-based (CD34, PBMC, BLT)), ... End User (Pharmaceutical & Biotech Companies, CRO) - Global ... the global Humanized Mouse Model Market for the forecast ... to reach USD 116.0 Million by 2021 from USD ...
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... entered into an underwriting agreement with Rodman & Renshaw, ... LLC, as sole book running manager and representative of several ... on a firm commitment basis a minimum of 2,105,264 ... warrants to purchase a minimum of 1,052,632 shares of ...
(Date:1/23/2017)... N.J. , Jan. 23, 2017   Enteris ... feasibility study agreement with Sanofi to leverage ... delivery platform, Peptelligence™, to develop an oral formulation of ... Joel Tune , Chief Executive Officer and Executive ... is further validation of the tremendous value our Peptelligence ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Vice President, Preclinical Safety and Senior Director, Safety Pharmacology. Dr. Thomas earned ... , Dr. Thomas’ career as an academic and industry preclinical drug developer ...
Breaking Biology Technology: